Abbvie Inc ABBV:NYSE

RT Quote | NYSE | USD
Last | 04/14/21 EDT
105.90quote price arrow down-1.02 (-0.95%)
Volume
6,718,619
52 week range
79.11 - 113.41

...

Loading . . .
  • Open106.22
  • Day High106.67
  • Day Low105.58
  • Prev Close105.90
  • 52 Week High113.41
  • 52 Week High Date01/13/21
  • 52 Week Low79.11
  • 52 Week Low Date10/29/20

Key Stats

  • Market Cap186.895B
  • Shares Out1.765B
  • 10 Day Average Volume7.03M
  • Dividend5.20
  • Dividend Yield4.91%
  • Beta0.80
  • YTD % Change-1.17

KEY STATS

  • Open106.22
  • Day High106.67
  • Day Low105.58
  • Prev Close105.90
  • 52 Week High113.41
  • 52 Week High Date01/13/21
  • 52 Week Low79.11
  • 52 Week Low Date10/29/20
  • Market Cap186.895B
  • Shares Out1.765B
  • 10 Day Average Volume7.03M
  • Dividend5.20
  • Dividend Yield4.91%
  • Beta0.80
  • YTD % Change-1.17

RATIOS/PROFITABILITY

  • EPS (TTM)2.71
  • P/E (TTM)39.08
  • Fwd P/E (NTM)8.47
  • EBITDA (MRQ)19.092B
  • ROE (MRQ)185.77%
  • Revenue (MRQ)45.804B
  • Gross Margin (MRQ)66.41%
  • Net Margin (MRQ)10.09%
  • Debt To Equity (MRQ)658.12%

EVENTS

  • Earnings Date04/30/2021
  • Ex Div Date04/14/2021
  • Div Amount1.30
  • Split Date-
  • Split Factor-

Related Video

VIDEO1:4101:41
Final Trades: Roku, Lam Research, AbbVie & more

Profile

MORE
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's...
Richard Gonzalez
Chairman
Laura Schumacher
Vice Chairman - Management
Michael Severino M.D.
President
Robert Michael
Chief Financial Officer
Henry Gosebruch
Executive Vice President
Address
1 N Waukegan Rd
North Chicago, IL
60064-1802
United States

Top Peers

SYMBOLLASTCHG%CHG
MRK
Merck & Co Inc
76.40-0.03-0.04%
NVS
Novartis AG
86.75UNCHUNCH
PFE
Pfizer Inc
37.17+0.01+0.03%
BMY
Bristol-Myers Squibb Co
63.81+0.23+0.36%
LLY
Eli Lilly and Co
183.00+0.47+0.26%